UTMB researchers, led by Pei-Yong Shi and Xuping Xie, report on bivalent vaccine neutralization against new Omicron subvariants in Nature Medicine (PubMed: Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster.).
The study was highlighted by CNBC (Omicron boosters are weaker against BQ.1.1 subvariant that is rising in U.S., study finds).